CiteFacts · FDA Drug Shortages · FDA source
Valproate Sodium Injection
Status
FDA currently lists this ingredient in shortage.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| Fresenius Kabi USA, LLC | Valproate Sodium, Injection, 100 mg/1 mL (NDC 63323-494-05) | Available | 08/04/2026 |
| Hikma Pharmaceuticals USA, Inc. | Valproate Sodium, Injection, 500 mg/5 mL (NDC 0143-9785-10) | Available | 08/13/2026 |
Source facts
Grouped generic ingredient: Valproate Sodium Injection · 2 package records · Latest FDA row update: 08/13/2026
Therapeutic categories: Neurology
Dosage forms: Injection
Routes: INTRAVENOUS
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.